2020 Boryeong Pharmaceutical 4.45%p, Daewoong Pharmaceutical 3.22%p, Yuyu Pharmaceutical 2.84%p
Ildong Pharmaceutical 9.05%p, Shinpoong Pharmaceutical 5.45%p, Hanall Biopharma 2.30%p reduction
Last year, it was found that the shares of the largest shareholders of Boryeong Pharmaceutical and Daewoong Pharmaceutical increased significantly.
As a result of compile reports of changes in stocks owned by major listed pharmaceutical companies, including the largest shareholders in 2020, it was confirmed that the share of the two companies increased by more than 3%p last year.
Among listed pharmaceutical companies last year, the largest shareholder’s share of the largest shareholder was Boryeong Pharmaceutical, which increased by 4.45%p from 52.75% at the beginning of the year to 57.20% at the end of the year.
Daewoong Pharmaceutical’s largest shareholders’ stake also increased 3.22%p from 51.33% to 54.55%, while Yuyu Pharmaceutical’s share increased 2.84%p from 35.19% to 38.03%.
In addition, Chong Kun Dang Bio increased 1.90%p from 37.26% to 39.16%, and Dongwha Pharm increased 1.30%p from 32.37% to 33.67%. done.
Following these, Chong Kun Dang’s share of the largest shareholder rose 0.89%p, JW Pharmaceutical’s 0.81%p, Wooridul Pharmaceutical’s 0.72%p, Hwanin Pharmaceutical’s 0.69%p, and Dong-A ST’s 0.50%p.
In addition, the shares of the largest shareholders of United Pharm, Daewon Pharm, Hyundai Pharm, Hana Pharm, Hanmi Pharm, Seoul Pharm, and JW Life Science rose slightly, but the increase did not exceed 1%p.
On the other hand, during the same period, Ildong Pharmaceutical’s largest shareholders’ stake fell sharply by 47.7%hf 9.05%p from 56.12%.
In November of last year, as Sunrise Holdings, which had been tied up as a related party to the largest shareholder, sold more than half of its holdings and terminated the special relationship, the stake in the largest shareholder decreased significantly.
Shinpoong Pharmaceutical also saw a sharp decline in the stake of Songam, the largest shareholder, and the largest shareholder’s stake fell 5.46%p from 40.85% to 35.39%.
As Shinpoong Pharm’s stock price rose sharply, Songam’s stake in Songam declined significantly as Aden Partners, who bought the exchange bonds issued by Songam in the past, exchanged them for stocks and disposed of them.
In addition, Hanall Biopharma’s largest shareholder’s stake decreased by 2.30%p from 33.26% to 30.96%, Green Cross fell 1.49%p from 52.89% to 51.40%. done.
In addition, Aprogen Pharmaceuticals 0.97%p, Samil Pharmaceuticals 0.85%p, Jeil Pharmaceuticals 0.66%p, Ilyang Pharmaceuticals 0.32%p, Ilsung Pharmaceuticals 0.13%p, Bukwang Pharmaceuticals 0.11%p, Kwangdong Pharmaceuticals 0.10%p , Yuhan Corporation, Dongkuk Pharmaceutical, and Dongsung Pharmaceutical fell by 0.01%p.
Meanwhile, among them, Dongkuk Pharm, Seoul Pharm, Wooridul Pharm, and Yuyu Pharm were the largest shareholders last year due to the transfer and donation of shares.
Copyright © Medical News Unauthorized reproduction and redistribution prohibited